Inotidine Tablets (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
SPC Co., Ltd.
MFDS item code 201206838 · Approved 2012.09.19
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
This medication is used for various gastrointestinal disorders such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent Mendelson's syndrome during surgery and anesthesia, and aids in the treatment of gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is effective in improving mucosal damage due to acute and chronic gastritis exacerbations and upper gastrointestinal bleeding. This drug protects the gastric mucosa and is used for improving symptoms of heartburn and acid reflux due to excessive gastric acid.
Administer ranitidine 150 mg orally per dose twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies when coadministered to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine per dose twice daily for 8 weeks, or 300 mg once daily at bedtime. The dose may be increased to 150 mg per dose 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg of this medicine per dose 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and administer 150 mg of this medicine per dose twice daily. 5) Premedication before anesthesia (prevention of Mendelson’s syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, swelling) in the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg of this medicine per dose once daily at bedtime. 3. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient’s condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
For patients aged 12 years and older, administer 75 mg of this medicine per dose orally twice daily (for liquid formulation only). For patients aged 8 〜 18 years, up to 150 mg per dose (2 mg/kg of body weight) may be administered twice daily.
This medication should not be used by patients who have had hypersensitivity reactions to any ingredient in this drug. It should not be given to patients with a history of acute porphyria, as it may exacerbate symptoms. This drug contains lactose, so patients with lactose intolerance or related genetic disorders should not take it. Patients with impaired renal function need dose adjustment as it may accumulate in the body, and those with reduced liver function should also use it cautiously. Patients with a history of drug allergies, elderly patients, and those taking non-steroidal anti-inflammatory drugs should also be administered this medication carefully. Gastric cancer symptoms may be masked; therefore, gastric ulcer patients or individuals over middle age who develop new digestive symptoms should verify malignancy before use. Patients with Helicobacter pylori infection and gastric/duodenal ulcers need to undergo bacterial eradication treatment. Rarely, while taking this medication, symptoms such as anaphylactic shock, skin rash, blood abnormalities, liver dysfunction, heart rhythm abnormalities, gastrointestinal symptoms, and neurological symptoms may occur, so if any abnormal symptoms appear, discontinue use immediately and consult a doctor. During treatment, closely observe the condition of the disease, and switch to other treatment methods if there is no effect. Elderly patients or those with chronic diseases may have an increased risk of pneumonia, and caution should be taken to avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This medication may affect the absorption or excretion of other drugs, so dose adjustments of concurrent medications may be necessary. Especially for patients taking anticoagulants, such as warfarin, frequent blood tests should be performed to reduce the risk of bleeding. Pregnant or breastfeeding women should consult a doctor before taking this medication, as its safety has not been established, and it should only be used if the benefits outweigh the risks. Safety in children has not been fully confirmed, so caution is required for use. Elderly patients may have reduced kidney function, so they should take this medication cautiously, either by reducing the dose or increasing the dosing interval. False-positive results may occur in some tests while taking this medication, so be mindful of the testing methods. In case of overdose, appropriate treatment such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may be required. Store out of reach of children and do not transfer to other containers for safety. Long-term use may increase bacterial growth in the stomach due to reduced gastric acid secretion, so caution is required, and an ophthalmological examination may be necessary due to its affinity with ocular melanin.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it must be stored in a container that does not allow light to enter. To maintain the efficacy of the drug, it is important to store it at room temperature between 1 to 30 degrees Celsius.
Pale yellow to yellow round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
SPC Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.